An apparatus comprises an absorbent body, a non-permeable feature, and a port feature. The absorbent body comprises a wicking feature. The non-permeable feature is coupled with the absorbent body. The non-permeable feature and at least a portion of the absorbent body are configured to fit in an opening in a paranasal sinus wall. The port feature extends through the absorbent body. The port feature defines a lumen. The wicking feature extends outwardly relative to the port lumen. During installation of the apparatus, the non-permeable feature is positioned in an opening in the paranasal sinus wall. The absorbent body is oriented such that the wicking feature is in contact with mucosal tissue in a sinus cavity defined by the paranasal sinus wall. A proximal portion of the absorbent body is positioned outside the paranasal sinus wall.

A nasal balloon catheter and sponge unit is provided for stopping posterior epistaxis (nosebleed) in a quick and adjustable manner. The unit can be easily introduced into the bleeding nasal passage of a patient by a health care provider. Once inserted in the patient's nasal passage, the unit operates through inflation of a posterior balloon via a catheter, acting to stop the posterior bleed. In some embodiments, a second (anterior) balloon covers the inside of the nasal passage and is inflated subsequent to the inflation of the posterior balloon. Excess blood coming out of the nasal passage in the front is stopped by an absorbable sponge. If the packing is loose and blood escapes from the back of the nasal passage, a nut is utilized to squeeze the catheter against the nostril, hence more tightly pulling the posterior balloon to stop the blood.

A hemostatic equipment has a pallet and an inflatable pillar. The pallet has a holder used for a patient to hold, providing foolproof effect in an operation direction to ensure that the inflatable pillar may enter a nasal cavity of a patient in a correct direction. The inflatable pillar has a head exposed with a pressing surface for pressing a bleeding site inside a nasal cavity of a patient to stop bleeding.

A rhinotillexis apparatus, devised for controlled insertion into a nasal cavity for collection and removal of mucus therefrom, includes a spatulate head member having a first surface and a second surface convergent at an anterior edge, a neck portion, a shield member, and a handle member for dexterous wielding in the hands of a user. The head member is tautly overlain with an absorbent layer. The shield member prevents over-insertion of the head member into the nasal cavity and shields a user's hands from contamination with mucus during use. Disposal of the apparatus after single-use decreases potential for cross-contamination.

A device for stopping bleeding from inside a nostril of a human nose. The device being formed from a sponge-like material that has an upper portion having a size and shape adapted for insertion into the nostril of a human nose and the upper portion also being formed integral with a handle, wherein an outer surface of the upper portion being coated with a material that causes blood to clot.

An implantable article comprising a dissolvable sponge derived from the mixture of chitosan, a first polysaccharide and a second polysaccharides. The polysaccharides have different number average molecular weight characteristics to enable the control of the mechanical features of the sponge.

The present invention provides a device that can move inside a biological conduit such as an intestinal tract for sampling the content therein, and a process thereof. While moving along the intestinal tract, the device can continuously collect the content in the intestinal tract. One or more convoy belts having an adsorbent layer are configured to continuously absorb and preserve the collected intestinal content. The belt loaded with the sample may be used to establish a chemical, biochemical and microbiological spectrum along the length of the intestinal tract.

The various embodiments of the subject invention included herein provide devices and methods to deliver nasal packing material to a body lumen, cavity, or other anatomical structure along with methods of use of the same.

A system includes a platform configured for insertion into a user's nostril and a catheter. The platform includes a board having first and second major surfaces and a support extending from the board. The support includes an aperture therethrough. The catheter includes an inflatable tube and a lumen having first and second ends, the first end connected to the tube and the second end connected to a pressurized fluid source for inflating the tube. The tube is configured for insertion through the aperture. A method includes inserting a platform into a user's nostril, inserting a catheter through an aperture of the platform, and inflating a tube of the catheter. Inflating the tube is accomplished by introducing a pressurized fluid through a lumen of the catheter, to thereby cause the tube to conform to a passage of the user's nasal or pharyngeal region.

Described herein are wound dressings, methods for their production and components for use therein. Described herein are a knitted structure including a blend of gelling fibres and non-gelling fibres wherein the yarn includes at least 50% w/w gelling fibres, a three-dimensional textile material including gelling fibres, and a yarn including a blend of gelling and non-gelling fibres which may be used in their production, the knitted structure and three-dimensional textile material being suitable for use as wound dressings or as components of composite wound dressings. The wound dressings may be adapted for use in negative pressure wound therapy (NPWT). It has been found that the incorporation of gel-forming fibres provides a material which has a high absorbency, enabling good transfer of exudates away from a wound, which retains structural integrity, and which is non-adherent and easily removed from the wound.